Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
Front Oncol
2019 May 22;9:406. doi: 10.3389/fonc.2019.00406.
Show Gene links
Show Anatomy links
In vitro and in vivo Induction of p53-Dependent Apoptosis by Extract of Euryale ferox Salisb in A549 Human Caucasian Lung Carcinoma Cancer Cells Is Mediated Through Akt Signaling Pathway.
Nam GH
,
Jo KJ
,
Park YS
,
Kawk HW
,
Kim SY
,
Kim YM
.
???displayArticle.abstract???
Lung cancer is one of the leading causes of death, and mortality rates have steadily been increasing. Recently, several studies were conducted to develop novel, physiologically active compounds from medicinal plant extracts. Several plant-derived extracts and molecules regulate and inhibit signaling molecules associated with the growth and proliferation of cancer cells. Euryale ferox salisb is a medicinal plant that is effective against different types of cancers. In this study, we investigated the apoptotic effects of E. ferox salisb extract (ESE) in A549 lung cancer cells, exerted by the inhibition of the Akt protein and activation of the p53 protein. Our results show that ESE induces apoptosis via the regulation of mitochondrial outer membrane potential and generation of reactive oxygen species (ROS). We demonstrate that apoptosis is induced in a p53-dependent manner when cells are treated with pifithrin-α (a p53 inhibitor) and LY294002 (an Akt inhibitor). The apoptotic effects from ESE were observed in vivo in Balb/c-nu mice bearing A549 xenografts. Altogether, these results suggest that E. ferox salisb extracts exert anti-cancer effects in a p53-dependent manner.
Figure 1. The identification of active compounds in ESE. (A) HPLC profiles of ESE (total extract) (B) HPLC profiles of standard resveratrol (33.489). (C) HPLC profiles of standard alliin (5.595). (D) HPLC profiles of standard gallic acid (10.583). X-axis represents retention time (min), Y-axis represents absorption units (AU). Detector was set at 240 nm.
Figure 2. ESE suppresses A549 Human Caucasian lung carcinoma cancer cells proliferation Cell proliferation rate was measured by MTT assay. And LDH assay was performed for assessing cell deaths. Cytotoxicity was induced by ESE. (A) Various cancer cell lines were treated with the indicated concentrations of ESE (150 μg/ml) for 24 h. (B) Various cancer cell lines were treated with the indicated concentrations of ESE (150 μg/ml) for 6–48 h. The most effective anti-cancer effect in 24 h. Anti-cancer effect in 48 h also worked well, but the difference was not significant compared to 24 h. (C) MRC-5 Human lung Fibroblast cells were treated with various concentrations of ESE for 24 h through MTT assay. (D) MRC-5 Human lung Fibroblast cells were treated with various concentrations of ESE for 24 h through LDH assay. (E) A549 Human Caucasian lung carcinoma cancer cell proliferation rate was measured by MTT assay (F) A549 Human Caucasian lung carcinoma cancer cell viability rate was measured by LDH assay. N represents untreated cells and delivery is a control for treatment without ESE. The statistical analysis of the data was carried out by use of ANOVA test. ***P < 0.001 compared to N (untreated groups). N.S; not significant (each experiment, n = 3). The error bars represent the standard error.
Figure 3. ESE induces apoptosis in A549 Human Caucasian lung carcinoma cancer cells. (A) Cells were treated with the indicated concentrations of ESE for 24 h. Cells stained with Muse™ Annexin V and Dead Cell Assay kit and analyzed by Muse™ Cell Analyzer. Data shows four cell populations—Live, Dead, Late Apoptosis/Dead, Early Apoptosis. Y-axis is labeled for viability [stained by 7-AAD (a dead cell marker)] and X-axis is labeled for Annexin V [binding with phosphatidylserine(PS)]. (B) Cell apoptosis observed using Hoechst 33342 staining and image-based monitoring. Cells were treated with the indicated concentrations of ESE for 24 h. Florescence detected by confocal microscope and Image-based monitoring detected by optical microscope. N represents untreated cells. (C) Nuclear abnormalities rate measured. The number of nuclear counted from the randomly selected fields. N represents untreated cells. The statistical analysis of the data was carried out by use of ANOVA test. ***P < 0.001 compared to N (untreated groups). N.S; not significant (each experiment, n = 3). The error bars represent the standard error.
Figure 4. Observation of various apoptosis inducers in cancer cells. (A) Cells were treated with the indicated concentrations of ESE (50–150 μg/ml) for 24 h. Cells stained with Muse™ Cell Cycle Kit and analyzed by Muse™ Cell Analyzer. X-axis is labeled for propidium iodide (PI) and Y-axis is numbers of cells. propidium iodide (PI) discriminates cells at different stages of the cell cycle, based on differential DNA content. (B) Representative histograms from Muse™ Cell Analyzer in the A549 Human Caucasian lung carcinoma cancer cells treated with various concentration of ESE. Assays were performed in triplicate. (C) Cells stained with Muse Oxidative Stress Kit and analyzed by Muse™ Cell Analyzer. X-axis is labeled for ROS positive cells. It is based on dihydroethidium (DHE), a well-characterized reagent that has been extensively used to detect ROS. The reagent is cell permeable and it has long been postulated that DHE upon reaction with superoxide anions undergoes oxidation to form the DNA-binding fluorophore ethidium bromide or a structurally similar product which intercalates with DNA resulting in red fluorescence. (D) Cells stained with Muse™ MitoPotential Kit and analyzed by Muse™ Cell Analyzer. This parameter is displayed in the X-axis. A dead cell marker (7-AAD) is also used as an indicator of cell membrane structural integrity and cell death. It is excluded from live, healthy cells, as well as early apoptotic cells. Dead cells thus show increased fluorescence in the Y-axis. (E) Activation of Caspase-3/7 was analyzed by Apo-ONE Homogeneous Caspase 3/7 Assay Kit. Cells were treated with ESE (50–150 μg/ml) for 24 h. N represents untreated cells. The statistical analysis of the data was carried out by use of ANOVA test. *P < 0.05, ***P < 0.001 compared to N (untreated groups). N.S.; not significant (each experiment, n = 3). The error bars represent the standard error.
Figure 5. ESE induce apoptosis through Akt signaling pathway suppression and p53-dependent manner. (A) The expression of (cleaved) PARP, (p)Aktser473, (p)MDM2ser166, p53, COX-2, pro-caspase 3, Bcl-2, Bak, Bax, and β-actin were analyzed by Western blot analysis. The β-actin probe served as protein-loading control. The figures show non-adjacent bands from the same blot. (B) The expression of (cleaved) PARP, (p)Aktser473, (p)MDM2ser166, p53, COX-2, pro-caspase 3, Bcl-2, Bak, Bax, and β-actin were analyzed by Western blot analysis. Cells were pre-treated with 20 μM LY294002 or 40 μM Pifithrin-α for 60 min and co-treated with 100 μg/ml ESE 24 h. The β-actin probe served as protein-loading control. The figures show non-adjacent bands from the same blot. (C) Cell proliferation rate was measured by MTT assay. Cells were pre-treated with 20 μM LY294002 or 40 μM Pifithrin-α for 60 min and co-treated with 100 μg/ml ESE 24 h. (D) Activation of Caspase-3/7 was analyzed by Apo-ONE Homogeneous Caspase 3/7 Assay Kit. Cells were pre-treated with 20 μM LY294002 or 40 μM Pifithrin-α for 60 min and co-treated with 100 μg/ml ESE 24 h. N represents untreated cells. The statistical analysis of the data was carried out by use of ANOVA test. *P < 0.05, ***P < 0.001 compared to N (untreated groups). ###P < 0.001 compared between ‘ESE’ with ‘P+ESE’. N.S.; not significant (each experiment, n = 3). The error bars represent the standard error.
Adams,
The Bcl-2 protein family: arbiters of cell survival.
1998, Pubmed
Adams,
The Bcl-2 protein family: arbiters of cell survival.
1998,
Pubmed
Ahmed,
Antidiabetic, antioxidant, antihyperlipidemic effect of extract of Euryale ferox salisb. with enhanced histopathology of pancreas, liver and kidney in streptozotocin induced diabetic rats.
2015,
Pubmed
,
Echinobase
Baek,
Cellular Anti-Melanogenic Effects of a Euryale ferox Seed Extract Ethyl Acetate Fraction via the Lysosomal Degradation Machinery.
2015,
Pubmed
,
Echinobase
Brentnall,
Caspase-9, caspase-3 and caspase-7 have distinct roles during intrinsic apoptosis.
2013,
Pubmed
Budihardjo,
Biochemical pathways of caspase activation during apoptosis.
1999,
Pubmed
Cully,
Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis.
2006,
Pubmed
Danial,
Cell death: critical control points.
2004,
Pubmed
Fan,
Caspase family proteases and apoptosis.
2005,
Pubmed
Ferlay,
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.
2015,
Pubmed
Fresno Vara,
PI3K/Akt signalling pathway and cancer.
2004,
Pubmed
Gonzalvez,
New insights into apoptosis signaling by Apo2L/TRAIL.
2010,
Pubmed
Green,
The pathophysiology of mitochondrial cell death.
2004,
Pubmed
Guo,
Comparing different physical factors on serum TNF-α levels, chondrocyte apoptosis, caspase-3 and caspase-8 expression in osteoarthritis of the knee in rabbits.
2011,
Pubmed
Hanif,
Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway.
1996,
Pubmed
Hockenbery,
Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death.
1990,
Pubmed
Kennedy,
The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal.
1997,
Pubmed
Kim,
Apoptosis-induced effects of extract from Artemisia annua Linné by modulating PTEN/p53/PDK1/Akt/ signal pathways through PTEN/p53-independent manner in HCT116 colon cancer cells.
2017,
Pubmed
Kim,
Licochalcone A induces apoptosis in malignant pleural mesothelioma through downregulation of Sp1 and subsequent activation of mitochondria-related apoptotic pathway.
2015,
Pubmed
Ko,
The Role of Resveratrol in Cancer Therapy.
2017,
Pubmed
Kussie,
Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain.
1996,
Pubmed
Lee,
Antioxidant activity of extracts from Euryale ferox seed.
2002,
Pubmed
,
Echinobase
Li,
Mono- versus polyubiquitination: differential control of p53 fate by Mdm2.
2003,
Pubmed
Lim,
Apoptotic effects of extract from Cnidium monnieri (L.) Cusson by adenosine monosphosphate-activated protein kinase-independent pathway in HCT116 colon cancer cells.
2016,
Pubmed
Lim,
Ethanol extract from Cnidium monnieri (L.) Cusson induces cell cycle arrest and apoptosis via regulation of the p53‑independent pathway in HepG2 and Hep3B hepatocellular carcinoma cells.
2018,
Pubmed
Little,
Patterns of surgical care of lung cancer patients.
2005,
Pubmed
Luo,
Targeting the PI3K-Akt pathway in human cancer: rationale and promise.
2003,
Pubmed
McLachlan,
Pancratistatin: a natural anti-cancer compound that targets mitochondria specifically in cancer cells to induce apoptosis.
2005,
Pubmed
Michael,
The p53-Mdm2 module and the ubiquitin system.
2003,
Pubmed
Mousa,
Anti-angiogenesis efficacy of the garlic ingredient alliin and antioxidants: role of nitric oxide and p53.
2005,
Pubmed
Nicholson,
Apoptosis. Life and death decisions.
2003,
Pubmed
Ohno,
Induction of apoptosis by gallic acid in lung cancer cells.
1999,
Pubmed
Osaki,
PI3K-Akt pathway: its functions and alterations in human cancer.
2004,
Pubmed
Porter,
Emerging roles of caspase-3 in apoptosis.
1999,
Pubmed
Shimizu,
Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC.
1999,
Pubmed
Soner,
Induced growth inhibition, cell cycle arrest and apoptosis in CD133+/CD44+ prostate cancer stem cells by flavopiridol.
2014,
Pubmed
Speidel,
Transcription-independent p53 apoptosis: an alternative route to death.
2010,
Pubmed
Tait,
Mitochondria and cell death: outer membrane permeabilization and beyond.
2010,
Pubmed
Teiten,
Curcumin-the paradigm of a multi-target natural compound with applications in cancer prevention and treatment.
2010,
Pubmed
Vanden Berghe,
Regulated necrosis: the expanding network of non-apoptotic cell death pathways.
2014,
Pubmed
Vergara,
Antitumor activity of the dietary diterpene carnosol against a panel of human cancer cell lines.
2014,
Pubmed
Vivanco,
The phosphatidylinositol 3-Kinase AKT pathway in human cancer.
2002,
Pubmed
Vousden,
Blinded by the Light: The Growing Complexity of p53.
2009,
Pubmed
Wang,
Molecular mechanism of catalase activity change under sodium dodecyl sulfate-induced oxidative stress in the mouse primary hepatocytes.
2016,
Pubmed
Yang,
Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked.
1997,
Pubmed